Cargando…

SPG302 Reverses Synaptic and Cognitive Deficits Without Altering Amyloid or Tau Pathology in a Transgenic Model of Alzheimer’s Disease

Alzheimer’s disease (AD) is conceptualized as a synaptic failure disorder in which loss of glutamatergic synapses is a major driver of cognitive decline. Thus, novel therapeutic strategies aimed at regenerating synapses may represent a promising approach to mitigate cognitive deficits in AD patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Trujillo-Estrada, Laura, Vanderklish, Peter W., Nguyen, Marie Minh Thu, Kuang, Run Rong, Nguyen, Caroline, Huynh, Eric, da Cunha, Celia, Javonillo, Dominic Ibarra, Forner, Stefania, Martini, Alessandra C., Sarraf, Stella T., Simmon, Vincent F., Baglietto-Vargas, David, LaFerla, Frank M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804111/ https://www.ncbi.nlm.nih.gov/pubmed/34738197 http://dx.doi.org/10.1007/s13311-021-01143-1

Ejemplares similares

Tau underlies synaptic and cognitive deficits for type 1, but not type 2 diabetes mouse models
por: Trujillo‐Estrada, Laura, et al.
Publicado: (2019)

miR‐181a negatively modulates synaptic plasticity in hippocampal cultures and its inhibition rescues memory deficits in a mouse model of Alzheimer’s disease
por: Rodriguez‐Ortiz, Carlos J., et al.
Publicado: (2020)

Impaired AMPA signaling and cytoskeletal alterations induce early synaptic dysfunction in a mouse model of Alzheimer's disease
por: Baglietto‐Vargas, David, et al.
Publicado: (2018)

Reply to Peng and Zhao: Loss of endocytic protein TOM1 in Alzheimer’s disease
por: Martini, Alessandra C., et al.
Publicado: (2020)

Amyloid-beta impairs TOM1-mediated IL-1R1 signaling
por: Cadete Martini, Alessandra, et al.
Publicado: (2019)

Intra- and extracellular β-amyloid overexpression via adeno-associated virus-mediated gene transfer impairs memory and synaptic plasticity in the hippocampus
por: Forner, Stefania, et al.
Publicado: (2019)

Hippocampal Adaptive Response Following Extensive Neuronal Loss in an Inducible Transgenic Mouse Model
por: Myczek, Kristoffer, et al.
Publicado: (2014)

Generation of a humanized Aβ expressing mouse demonstrating aspects of Alzheimer’s disease-like pathology
por: Baglietto-Vargas, David, et al.
Publicado: (2021)

An integrated modelling methodology for estimating global incidence and prevalence of hereditary spastic paraplegia subtypes SPG4, SPG7, SPG11, and SPG15
por: Vander Stichele, Geert, et al.
Publicado: (2022)

Alimentation SPG Test
por: Guillet, J
Publicado: (1993)

Lysosomal abnormalities in hereditary spastic paraplegia types SPG15 and SPG11
por: Renvoisé, Benoît, et al.
Publicado: (2014)

Systematic phenotyping and characterization of the 5xFAD mouse model of Alzheimer’s disease
por: Forner, Stefania, et al.
Publicado: (2021)

SPG15 protein deficits are at the crossroads between lysosomal abnormalities, altered lipid metabolism and synaptic dysfunction
por: Marrone, Lara, et al.
Publicado: (2022)

SPG11 Presenting with Tremor
por: Schneider, Susanne A., et al.
Publicado: (2012)

Genetic Knockdown of Brain-Derived Neurotrophic Factor in 3xTg-AD Mice Does Not Alter Aβ or Tau Pathology
por: Castello, Nicholas A., et al.
Publicado: (2012)

Interaction between AP-5 and the hereditary spastic paraplegia proteins SPG11 and SPG15
por: Hirst, Jennifer, et al.
Publicado: (2013)

Early long-term administration of the CSF1R inhibitor PLX3397 ablates microglia and reduces accumulation of intraneuronal amyloid, neuritic plaque deposition and pre-fibrillar oligomers in 5XFAD mouse model of Alzheimer’s disease
por: Sosna, Justyna, et al.
Publicado: (2018)

A Trem2(R47H) mouse model without cryptic splicing drives age- and disease-dependent tissue damage and synaptic loss in response to plaques
por: Tran, Kristine M., et al.
Publicado: (2023)

Systematic Phenotyping and Characterization of the 3xTg-AD Mouse Model of Alzheimer’s Disease
por: Javonillo, Dominic I., et al.
Publicado: (2022)

SPG/DPG/ÖPG Frühjahrstagung : Teilchenphysik
por: Collective
Publicado: (1987)

Rag GTPases and phosphatidylinositol 3-phosphate mediate recruitment of the AP-5/SPG11/SPG15 complex
por: Hirst, Jennifer, et al.
Publicado: (2021)

Human neural stem cells improve cognition and promote synaptic growth in two complementary transgenic models of Alzheimer's disease and neuronal loss
por: Ager, Rahasson R., et al.
Publicado: (2015)

Spatial coding defects of hippocampal neural ensemble calcium activities in the triple-transgenic Alzheimer’s disease mouse model
por: Lin, Xiaoxiao, et al.
Publicado: (2022)

Mutational spectrum of the SPG4 (SPAST) and SPG3A (ATL1) genes in Spanish patients with hereditary spastic paraplegia
por: Álvarez, Victoria, et al.
Publicado: (2010)

Mutational Spectrum of Spast (Spg4) and Atl1 (Spg3a) Genes In Russian Patients With Hereditary Spastic Paraplegia
por: Kadnikova, V. A., et al.
Publicado: (2019)

More autosomal dominant SPG18 cases than recessive? The first AD‐SPG18 pedigree in Chinese and literature review
por: Chen, Shuai, et al.
Publicado: (2021)

FRI302 Umar Durrani
por: Durrani, Umar Safwaan, et al.
Publicado: (2023)

Impaired Spatial Reorientation in the 3xTg-AD Mouse Model of Alzheimer’s Disease
por: Stimmell, Alina C., et al.
Publicado: (2019)

Neurometabolic Dysfunction in SPG11 Hereditary Spastic Paraplegia
por: Regensburger, Martin, et al.
Publicado: (2022)

7,8-Dihydroxyflavone, a Small Molecule TrkB Agonist, Improves Spatial Memory and Increases Thin Spine Density in a Mouse Model of Alzheimer Disease-Like Neuronal Loss
por: Castello, Nicholas A., et al.
Publicado: (2014)

S30.2 Risk infections and bioterrorism
Publicado: (2005)

Health Tract, No. 302: Amateur Physicians
Publicado: (1867)

Treatment of Alzheimer's Disease with Anti-Homocysteic Acid Antibody in 3xTg-AD Male Mice
por: Hasegawa, Tohru, et al.
Publicado: (2010)

"ISR Performance Report, Run 286 MD: 4300 F, 300 P, 302 F, 302 P"
por: Hoffmann, H
Publicado: (1973)

Multimodal MRI-Based Study in Patients with SPG4 Mutations
por: Rezende, Thiago J. R., et al.
Publicado: (2015)

Predominant cerebellar phenotype in spastic paraplegia 7 (SPG7)
por: Yahikozawa, Hiroyuki, et al.
Publicado: (2015)

SPG7 mutations are a common cause of undiagnosed ataxia
por: Pfeffer, Gerald, et al.
Publicado: (2015)

Severe axonal neuropathy is a late manifestation of SPG11
por: Manole, Andreea, et al.
Publicado: (2016)

Multigeneration family with dominant SPG30 hereditary spastic paraplegia
por: Roda, Ricardo H., et al.
Publicado: (2017)

Complicated SPG4 presenting with recurrent urinary tract infection
por: Oberoi, Kinsi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_njk0cpgkgqtak0qvnihu9etg3q